Presentation is loading. Please wait.

Presentation is loading. Please wait.

Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Mentor: A. Žmegač Horvat.

Similar presentations


Presentation on theme: "Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Mentor: A. Žmegač Horvat."— Presentation transcript:

1 Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Mentor: A. Žmegač Horvat

2 Sudden Cardiac Death Incidence (cases/year) Survival Worldwide ‹1% U.S % W. Europe ‹5%

3 Causes of Sudden Cardiac Death 80% - coronary artery disease 15% - cardiomyopathy 5% - other

4 Cardiomyopathy dilated cardiomyopathy hypertrophic cardiomyopathy arrythmogenic right ventricular cardiomyopathy left ventricular non-compaction restrictive cardiomyopathy

5 Cardiac Chanellopathies Brugada syndrome long QT syndrome short QT syndrome idiopathic VF short coupled Torsades

6 Brugada Syndrome first described in 1992 in 8 patients with aborted sudden cardiac death history since 1986 – Brugada brothers

7 Brugada Syndrome characterized by: –ECG findings of RBBB and persistent ST elevation in V1 – V3 –structurally normal hearts –propensity for life-threatening ventricular arrhythmias –J point elevation

8 Brugada Syndrome: ECG

9 Typical electrocardiogram of Brugada syndrome. Note the pattern resembling a right bundle branch block, the P-R prolongation and the ST elevation in leads V1-V3.

10 Brugada Syndrome: ECG

11 Spontaneous polymorphic ventricular tachycardia recorded during monitoring in a patient with Brugada syndrome. The arrhythmias are fast and need DC shock to terminate.

12 Brugada Syndrome: Clinical Features unexpectad sudden death syncope, seizures agonal nocturnal respirations affects male patients predominantly (8:1) cases reported worldwide

13 Brugada Syndrome: Incidence and Distribution responsible for up to 50% of sudden death victims with structurally normal hearts in Thailand recognized in Asia for decades: –Philippines: Bangungut = scream followed by sudden death during sleep –Thailand: Lai tai = death during sleep –Japan: Pokuri = unexpected death during sleep

14 Brugada Syndrome: ECG

15 12-lead ECG during administration of ajmaline (50 mg in 5 min). Note the progressive appearance of the ST elevation in V1-V3.

16 Brugada Syndrome: Factors / Drugs that Enhance ECG Pattern Na+ channel blockers alpha agonists, vagotonic agents, beta blockers fever alcohol, cocaine severe ischemia tricyclic antidepressants, antihistaminics

17 Brugada Syndrome: Genetics autosomal dominant 60 different mutations in the SCN5A (chromosome 3) gene have been linked to the syndrome failure of alpha subunit of sodium channel to express shift in voltage and time dependence on I(Na+) activation, inactivation or reactivation

18

19 Brugada Syndrome: Diagnosis symptoms: syncope, SCD (usually during sleep) physical exam: normal family history: strong history of SCD ECG: best test to identify Brugada patients –may require Flecainide or Procainamide to bring out typical findings –ST elevation, RBBB imaging tests: usually no underlying structural disease stress tests: symptoms and ECG findings not usually reproducible with exercise

20 Brugada Syndrome: Diagnostic Criteria major criteria: –1. presence of ECG marker in structurally normal hearts –2. appearance of ECG marker after administration of Na+ channel blockers minor criteria: –1. family history of sudden cardiac death –2. syncope of unknown origin –3. documented ventricular tachycardia/fibrillation –4. genetic mutation of ion channels

21 Brugada Syndrome: Treatment IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR (ICD) symptomatic with the disease: ICD asymptomatic with family history of SCD: with normal ECG – OBSERVE asymptomatic with prolonged H-V interval and inducible VT/VF: controversial ICD

22

23

24

25 Potential Antiarrhythmic Drugs in Brugada Syndrome Quinidine (non specific I blocker) Isoproterenol (open L type calcium channel) Cilostazol (augment I Ca)

26 Conclusion sudden cardiac death in Southeast Asia characteristic ECG pattern – ST elevation in V1 – V3 ICD implantation in symptomatic patients

27 Thank you!


Download ppt "Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Brugada’s Syndrome and Sudden Cardiac Death Petra Lovrec Mentor: A. Žmegač Horvat."

Similar presentations


Ads by Google